New Agent Approved for PSMA PET Scanning in Prostate Cancer ...Middle East

News by : (Medscape) -
The injectable radioactive diagnostic agent, piflufolastatF18 (PYLARIFY), is the first to be commercially available for use in positron-emission tomography (PET) imaging for men with prostate cancer. FDA Approvals

Hence then, the article about new agent approved for psma pet scanning in prostate cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New Agent Approved for PSMA PET Scanning in Prostate Cancer )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار